1.新闻网址︰
https://tinyurl.com/yxsqtq2l
2.新闻来源︰
Agencia Brasil 巴西通讯社
3.完整新闻标题
Gov’t announces purchase of 100 million doses of CoronaVac
政府宣布采购1亿剂CoronaVac
4.完整新闻内容︰
Brazil’s Health Ministry announced the signing of a contract with S?o Paulo
’s Butantan Institute for the purchase of up to 100 million doses of vaccin
e CoronaVac against COVID-19 in 2021, manufactured by the institute in colla
boration with Chinese pharmaceutical company Sinovac.
巴西卫生部宣布与圣保罗布坦坦研究所签署合同，将于2021年购买由该研究所与中国国
药合作生产的高达1亿剂的新冠疫苗CoronaVac。
The contract includes an initial purchase of 45 million units, with the poss
ibility of acquiring another 54 million later on. This model was adopted by
the ministry due to the lack of budget to trade the whole 100 million doses.
Today, Butantan Institute reported that the vaccine has an efficiency of 78
percent.
合同包括首次购买4500万剂，以后可能再购买5400万剂。该部之所以采用这一模式，是
因为缺乏整个1亿剂的经费预算。今天，布坦坦研究所报告说，这种疫苗的有效率为78%
。
At a press conference at the Planalto presidential palace Thursday (Jan. 7),
Health Minister Eduardo Pazuello talked about the contract of the purchase
of Coronavac and the situation regarding the vaccination against COVID-19.
卫生部长爱德华多·帕祖埃洛星期四（1月7日）在普兰阿尔托总统府举行的记者招待会
上谈到了购买CoronaVac的合同和疫苗接种情况。
Pazuello stated that the acquisition of the Coronavac batch was made possibl
e by the provisional presidential decree enacted Wednesday (6), which led to
the vaccine contract before the registration with Brazil’s national sanita
ry regulator Anvisa.
帕祖埃洛表示，周三（6日）颁布的临时总统令使购买CoronaVac成为可能，疫苗合同在
巴西卫生监督局（Anvisa）完成注册流程之前签署。
“The presidential decree authorizes the contract for vaccine and other supp
lies even before the registration is completed with Anvisa—which was not al
lowed before,” the minister declared.
“总统甚至在巴西完成登记之前就批准了疫苗和其他供应品的合同，这在以前是不允
许的，”卫生部长宣称。
The ministry plans to have up to 354 million doses available by 2021. This a
mount should comprise two million doses imported from Astrazeneca, in India,
10.4 million produced by Fiocruz by July, 110 million manufactured in Brazi
l by Fiocruz starting in August, 42.5 million from Covax Facility (probably
from Astrazeneca) and the 100 million Coronavac stemming from the contract w
ith Butantan Institute.
卫生部计划到2021年提供多达3.54亿剂疫苗。这一数额应包括从印度阿斯利康进口的200
万剂，7月前由Fiocruz生产的1040万剂，8月起由Fiocruz在巴西生产的1.1亿剂，Covax
工厂（可能来自阿斯利康）的4250万剂，以及与布坦坦研究所签订的合同中产生的1亿
剂CoronaVac。
Coronavac will cost approximately $10 a dose, requiring two doses per person
to be vaccinated. Astrazeneca, in turn, costs $3.75 a dose. On the latter,
Minister Eduardo Pazuello stated that just one dose would be given.
Coronavac每剂大约10美元，需要每人接种两剂疫苗。相反的，阿斯利康的价格是每剂
3.75元。关于后者，爱德华多·帕祖埃洛部长表示，只用注射一剂。
Minister Eduardo Pazuello has updated the three scenarios for the early stag
es of vaccination previously unveiled. In the best-case scenario, the proces
s starts on January 20 if laboratories obtain the emergency authorization wi
th Anvisa.
爱德华多·帕祖埃洛部长更新了此前公布的疫苗接种早期阶段的三种设想。在最好的情
况下，如果实验室获得Anvisa的紧急授权，接种流程将从1月20日开始。
In this hypothesis, 8 million doses should be available. The immunization sh
ould take place with the vaccines available, be them from Butantan Institute
or imported from Astrazeneca in India.
按照这种假设，应该有800万剂可用。免疫接种应使用现有疫苗，无论是来自布坦坦研究
所的疫苗，还是从印度阿斯利康进口的疫苗。
The second scenario would go from January 20 to February 10. The third would
last from February 10 to early March. Pazuello noted that the prediction is
that two domestic producers, Butantan and the Oswaldo Cruz Foundation, reac
h a manufacture capacity of 30 million doses a month still this year.
第二个阶段是从1月20日到2月10日。第三个阶段从2月10日持续到3月初。帕祖埃洛指出
，有两家国内生产商可以生产疫苗，它们分别是布坦坦研究所和Oswaldo Cruz基金会，
今年能够达到每月3000万剂的生产能力。
The minister said that the agency team is still negotiating with Pfizer, the
pharmaceutical company that has acquired vaccines from other countries. How
ever, he argued that the company has set requirements not well regarded by t
he ministry, such as no accountability for any side effect, the decision to
have the US as a forum to address any moves stemming from problems of this n
ature, and the stipulation of having Brazil provide material to dilute the v
accine.
巴西卫生部依然在和辉瑞公司谈判，辉瑞已经收到了来自其它国家的订单。不过他说辉
瑞和卫生部还有一些分歧，比如辉瑞要求对疫苗任何的副作用不负责任，他们决定和美
国制定一个分歧解决的机制，以及规定让巴西提供材料来稀释疫苗。
“We haven’t stopped negotiating with Pfizer. What do we want? We want it t
o provide a treatment compatible with our country, and tone down these claus
es. We can’t sign it this way. It offered 500 thousand in January, 500 thou
sand in February, and 2 million in March, 2 million in April, 2 million in M
ay, and 2 million in June. Think whether this can settle the issue in Brazil
. All vaccines offered by Pfizer in the first half-year can vaccinate half o
f the population of Rio de Janeiro,” the minister stressed.
“我们还没有停止与辉瑞的谈判。我们想要什么？我们希望它提供一种与我国相适应的
政策，淡化这些（苛刻的）条款。这样我们不能签。它在1月份出货50万剂，2月份出货
50万剂，3月份出货200万剂，4月份出货200万剂，5月份出价200万剂，6月份出价200万
剂。想想这能否解决巴西的问题。辉瑞公司上半年提供的所有疫苗只能供里约热内卢（
巴西首都）一半的人口接种。
Syringes
注射器
The representatives of the Health Ministry also talked about the provision o
f syringes. An auction was conducted, and concluded with three percent of th
e total forecast. President Bolsonaro stated that he would suspend the purch
ase of syringes until prices are down again.
卫生部的代表还谈到了提供注射器的问题。在竞标后，最终只成交了所有数量的3%。博
索纳罗总统表示，他将暂停购买注射器，直到价格再次下降。
The ministry’s Executive-Secretary elcio Franco, said there are 80 million
syringes that could be mobilized immediately for the beginning of the vaccin
ation, including the existing ones in states and municipalities. He added th
at the Ministry obtained 30 million syringes from manufacturers through admi
nistrative requests.
卫生部执行秘书elcio Franco说，目前有8000万支注射器可以用于疫苗接种，包括各州
和各市现有的注射器。他补充说，卫生部将通过行政命令从制造商那里获得了3000万支
注射器。
Another 40 million may be acquired in an international purchase with the Pan
-American Health Organization (PAHO), of which 8 million may come between la
te January and early February.
另一个4000万剂的采购可能来自泛美卫生组织（PAHO）的国际采购，其中800万剂可能来
自1月底至2月初。
5.附注、心得、想法︰
懒人包：
1.CoronaVac每剂10美元，需要注射两剂；阿斯利康的每剂3.75美元，只要注射一剂。
2.辉瑞不对疫苗造成的副作用承担任何责任。
3.巴西总统在巴西卫生监督局完成疫苗注册流程之前紧急批准了采购，这是没有先例的。
巴西总统之前不是说中国疫苗副作用大、效果不好么，现在看身体倒是挺诚实。